Key result
Small extracellular vesicles regulate CVD progression, and living myocardial slices provide a reliable study model.
Why the study?
The mechanisms driving altered small extracellular vesicle secretion and cargo content in cardiovascular disease remain undetermined, partly due to challenges isolating cardiac-derived sEVs.
This review highlights the role of small extracellular vesicles in cardiovascular disease progression and proposes the living myocardial slice as a physiologically relevant model for their investigation.
sEVs merit further mechanistic study in CVD; living myocardial slices extend research tools but should not yet change practice.
Cardiovascular disease remains the leading cause of death worldwide. Extracellular vesicles (EVs) play a regulatory role in homeostasis, associated with their contribution to cell-cell communication. Recently, it has been confirmed that they also regulate the progression of cardiovascular disease. Specifically, myocardial injury induces an increase in the secretion of small extracellular vesicles (sEVs), both in the cardiac microenvironment and peripheral circulation. Small extracellular vesicles (sEVs) are lipid bilayer particles within the size range of 35-200 nm and are secreted by all cell types. Their high content of bioactive cargo-primarily miRNA-is altered in response to external stimuli, leading to behavioral changes of the recipient cells. In the context of cardiovascular disease, this change leads to acute and long term functional, structural, and biochemical effects on the myocardium. However, the mechanism behind the altered sEVs secretion and their changes in content in the context of cardiovascular disease is yet to be determined. That is partially due to the challenges associated with the isolation of cardiac-derived sEVs, which are essential for the investigation of the mechanisms behind cardiovascular disease progression. Living myocardial slices (LMS) provide an ideal platform for the isolation and investigation of sEVs function in the myocardium. Indeed, LMS not only maintain the cellular complexity and architecture of the native adult myocardium but can also be cultured over days/weeks without significant alterations in cardiac function, making them a reliable model for sEVs isolation and characterization at multiple timepoints. This review aims to summarize recent findings on the effect of sEVs on the onset and progression of cardiovascular disease and to discuss different methods for their isolation from LMSs and the investigation of their functional, structural, and biochemical effect on the myocardium.
No takes yet. Share an insight, caveat, or question.
Koutentaki et al. (2025) conducted a review in Cardiovascular disease. Small extracellular vesicles (sEVs) and living myocardial slices (LMS) was evaluated. Small extracellular vesicles play a regulatory role in cardiovascular disease progression, and the living myocardial slice platform provides a reliable model for their isolation and characterization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: